Nova Leap Health Corp. to Present at the 12th Annual LD Micro Main Event
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
HALIFAX, Dec. 10, 2019 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX Venture 50™ ranked company focused on the home health care industry, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the 12th Annual LD Micro Main Event (“Main Event”) to be held December 10-11, 2019 at the Luxe Sunset Bel Air in Los Angeles, California. During the Main Event, Mr. Dobbin plans to discuss the following:Record Quarterly Results – Q3The quarter ending September 30, 2019 results were released on November 7, 2019 and highlighted:Nine consecutive quarters of revenue growth;Record quarterly revenues;
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/faf44875-8b8e-4525-98a2-a35e2b2ab6c5Record quarterly EBITDA;A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4aef5291-424e-4446-8738-488dbf718776Industry and StrategyThe expanding Home Care market and Nova Leap’s focus on dementia care;How Nova Leap has successfully employed its acquisition and post-acquisition strategies to achieve record financial results, including the best quarter in the Company’s history;How promoting from within the organization has helped the Company scale;How continued investment in care professional training, including dementia training, leads to better client service;Why expanding to South Central U.S. was appropriate after the Company’s success in building a regional platform in New England;The advantage of decentralized operations and the impact of positive incremental changes on operational leverage; andThe Company’s high insider ownership and Management’s desire for the Company to become a long-term compounder through the proper allocation of capital.Stock Option GrantThe Company has granted 1,555,000 incentive stock options to directors, officers, employees and consultants of the Company. The stock options are exercisable for a period of 10 years at an exercise price of CAD$0.45 per share and vest 25% immediately and 25% on each anniversary date of the stock option grant date. The options were granted under and are subject to the terms and conditions of the Company’s Stock Option Plan. About Nova LeapNova Leap is an acquisitive home health care services company operating in one of the fastest growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #10 Ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 5 different U.S. states: Vermont, New Hampshire, Massachusetts, Rhode Island and Oklahoma as well as Nova Scotia, Canada.About LD MicroLD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched the first pure microcap index (LDMi) to exclusively provide intraday information on the entire sector. LD Micro will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.For those interested in attending, please contact David Scher at email@example.com or visit www.ldmicro.com for more information.NON-GAAP MEASURES:Gross margin is service revenue less cost of services;Earnings before interest, taxes, depreciation and amortization (“EBITDA”), is calculated as the net loss, before acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation and stock-based compensation), interest expense, net of interest income and income tax expense.FORWARD LOOKING INFORMATION:Certain information in this press release may contain forward-looking statements, such as statements regarding future expansions and cost savings, the Company’s expected annualized recurring revenue run rate and plans regarding future acquisitions and financings. This information is based on current expectations and assumptions, including assumptions concerning the Company’s ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include regulatory changes affecting the home care industry, unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management’s current expectations and plans relating to the future. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.For further information:Christopher Dobbin, CPA, CA, Director, President and CEO Nova Leap Health Corp., T: 902 401 9480 F: 902 482 5177 firstname.lastname@example.orgCAUTIONARY STATEMENT:Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.